REFERENCES
1. Prince OA, Krunkosky TM, Sheppard ES, Krause DC. Modelling persistent
Mycoplasma pneumoniae infection of human airway epithelium. Cell
Microbiol 2018;20.
2. Liu J, Zhao F, Lu J, Xu H, Liu H, Tang X, Yang H, Zhang J, Zhao S.
High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma
pneumoniae DNA in lower airway associated with severity of pediatric
Mycoplasma pneumoniae pneumonia. BMC Infect Dis 2019;19:1045.
3. Salvatore CM, Fonseca-Aten M, Katz-Gaynor K, Gomez AM, Hardy RD.
Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae
clearance and sustains airway obstruction in murine pneumonia. Infect
Immun 2008;76:732-738.
4. Liu J, He R, Wu R, Wang B, Xu H, Zhang Y, Li H, Zhao S. Mycoplasma
pneumoniae pneumonia associated thrombosis at Beijing Children’s
hospital. BMC Infect Dis 2020;20:51.
5. Zhao C, Liu J, Yang H, Xiang L, Zhao S. Mycoplasma
pneumoniae-Associated Bronchiolitis Obliterans Following Acute
Bronchiolitis. Sci Rep 2017;7:8478.
6. Liu JR, Lu J, Dong F, Li HM, Liu H, Tang XL, Guo YL, Zhao SY. Low
Bacterial Co-infection Invalidates the Early Use of Non-anti-Mycoplasma
pneumoniae Antibiotics in Pediatric Refractory Mycoplasma pneumoniae
Pneumonia Patients. Front Pediatr 2018;6:296.
7. Leong MA, Nachajon R, Ruchelli E, Allen JL. Bronchitis obliterans due
to Mycoplasma pneumonia. Pediatr Pulmonol 1997;23:375-381.
8. Yan Y, Wei Y, Jiang W, Hao C. The clinical characteristics of
corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in
children. Sci Rep 2016;6:39929.
9. Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for
comparing biological themes among gene clusters. OMICS 2012;16:284-287.
10. Luo W, Brouwer C. Pathview: an R/Bioconductor package for
pathway-based data integration and visualization. Bioinformatics
2013;29:1830-1831.
11. Zheng R, Wan C, Mei S, Qin Q, Wu Q, Sun H, Chen CH, Brown M, Zhang
X, Meyer CA, et al. Cistrome Data Browser: expanded datasets and new
tools for gene regulatory analysis. Nucleic Acids Res
2019;47:D729-729D735.
12. Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X,
Gould J, Davis JF, Tubelli AA, Asiedu JK, et al. A Next Generation
Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell
2017;171:1437-1452.e17.
13. Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and
correlations in multidimensional genomic data. Bioinformatics
2016;32:2847-2849.
14. Lluch-Senar M, Cozzuto L, Cano J, Delgado J, Llórens-Rico V, Pereyre
S, Bebear C, Serrano L. Comparative ”-omics” in Mycoplasma pneumoniae
Clinical Isolates Reveals Key Virulence Factors. PLoS One
2015;10:e0137354.
15. Gao M, Wang K, Yang M, Meng F, Lu R, Zhuang H, Cheng G, Wang X.
Transcriptome Analysis of Bronchoalveolar Lavage Fluid From Children
With Mycoplasma pneumoniae Pneumonia Reveals Natural Killer and T
Cell-Proliferation Responses. Front Immunol 2018;9:1403.
16. Li J, Sun L, Xu F, Qi H, Shen C, Jiao W, Xiao J, Li Q, Xu B, Shen A.
Screening and Identification of APOC1 as a Novel Potential Biomarker for
Differentiate of Mycoplasma pneumoniae in Children. Front Microbiol
2016;7:1961.
17. Yu JL, Song QF, Xie ZW, Jiang WH, Chen JH, Fan HF, Xie YP, Lu G.
iTRAQ-based Quantitative Proteomics Study in Patients with Refractory
Mycoplasma pneumoniae Pneumonia. Jpn J Infect Dis 2017;70:571-578.
18. Abraham E. Coagulation abnormalities in acute lung injury and
sepsis. Am J Respir Cell Mol Biol 2000;22:401-404.
19. Engelmann B, Massberg S. Thrombosis as an intravascular effector of
innate immunity. Nat Rev Immunol 2013;13:34-45.
20. Fox KA, Kirwan DE, Whittington AM, Krishnan N, Robertson BD, Gilman
RH, López JW, Singh S, Porter JC, Friedland JS. Platelets Regulate
Pulmonary Inflammation and Tissue Destruction in Tuberculosis. Am J
Respir Crit Care Med 2018;198:245-255.
21. Middleton EA, Weyrich AS, Zimmerman GA. Platelets in Pulmonary
Immune Responses and Inflammatory Lung Diseases. Physiol Rev
2016;96:1211-1259.
22. Pitchford SC, Riffo-Vasquez Y, Sousa A, Momi S, Gresele P, Spina D,
Page CP. Platelets are necessary for airway wall remodeling in a murine
model of chronic allergic inflammation. Blood 2004;103:639-647.
23. Johansson ME, Thomsson KA, Hansson GC. Proteomic analyses of the two
mucus layers of the colon barrier reveal that their main component, the
Muc2 mucin, is strongly bound to the Fcgbp protein. J Proteome Res
2009;8:3549-3557.
24. Zhou C, Chen H, Han L, Xue F, Wang A, Liang YJ. Screening of genes
related to lung cancer caused by smoking with RNA-Seq. Eur Rev Med
Pharmacol Sci 2014;18:117-125.
25. Kobayashi K, Yagasaki M, Harada N, Chichibu K, Hibi T, Yoshida T,
Brown WR, Morikawa M. Detection of Fcgamma binding protein antigen in
human sera and its relation with autoimmune diseases. Immunol Lett
2001;79:229-235.
26. Schwartz JL. Fcgbp - A Potential Viral Trap in RV144. Open AIDS J
2014;8:21-24.
27. Wang Y, Liu Y, Liu H, Zhang Q, Song H, Tang J, Fu J, Wang X. FcGBP
was upregulated by HPV infection and correlated to longer survival time
of HNSCC patients. Oncotarget 2017;8:86503-86514.
28. Li C, Wang R, Su B, Luo Y, Terhune J, Beck B, Peatman E. Evasion of
mucosal defenses during Aeromonas hydrophila infection of channel
catfish (Ictalurus punctatus) skin. Dev Comp Immunol 2013;39:447-455.
29. Houben T, Harder S, Schlüter H, Kalbacher H, Hoffmann W. Different
Forms of TFF3 in the Human Saliva: Heterodimerization with IgG Fc
Binding Protein (FCGBP). Int J Mol Sci 2019;20.
30. Reeves EP, Ali T, Leonard P, Hearty S, O’Kennedy R, May FE, Westley
BR, Josenhans C, Rust M, Suerbaum S, et al. Helicobacter pylori
lipopolysaccharide interacts with TFF1 in a pH-dependent manner.
Gastroenterology 2008;135:2043-2054, 2054.e1-2.
31. Dolan B, Naughton J, Tegtmeyer N, May FE, Clyne M. The interaction
of Helicobacter pylori with the adherent mucus gel layer secreted by
polarized HT29-MTX-E12 cells. PLoS One 2012;7:e47300.
32. Xiong L, Wen Y, Miao X, Yang Z. NT5E and FcGBP as key regulators of
TGF-1-induced epithelial-mesenchymal transition (EMT) are associated
with tumor progression and survival of patients with gallbladder cancer.
Cell Tissue Res 2014;355:365-374.
33. Morrison G, Scognamiglio R, Trumpp A, Smith A. Convergence of cMyc
and β-catenin on Tcf7l1 enables endoderm specification. EMBO J
2016;35:356-368.
34. Chen Z, Ji Z, Ngiow SF, Manne S, Cai Z, Huang AC, Johnson J, Staupe
RP, Bengsch B, Xu C, et al. TCF-1-Centered Transcriptional Network
Drives an Effector versus Exhausted CD8 T Cell-Fate Decision. Immunity
2019;51:840-855.e5.
35. Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant
RA, Jacobson RM, Poland GA. Genome-wide genetic associations with IFNγ
response to smallpox vaccine. Hum Genet 2012;131:1433-1451.
36. Zhao Y, Ma G, Yang X. HDAC5 promotes Mycoplasma pneumoniae-induced
inflammation in macrophages through NF-κB activation. Life Sci
2019;221:13-19.
37. Choi IS, Byeon JH, Yoo Y, Lee KC, Choung JT. Increased serum
interleukin-5 and vascular endothelial growth factor in children with
acute mycoplasma pneumonia and wheeze. Pediatr Pulmonol 2009;44:423-428.
38. Wang SH, Li LH, Zou DM, Zheng XM, Deng J. Roles of the mammalian
target of rapamycin (mTOR) signaling pathway in the repair of
hyperoxia-induced acute lung injury. Adv Clin Exp Med 2020;29:13-23.
39. Liu NN, Flanagan PR, Zeng J, Jani NM, Cardenas ME, Moran GP, Köhler
JR. Phosphate is the third nutrient monitored by TOR in Candida albicans
and provides a target for fungal-specific indirect TOR inhibition. Proc
Natl Acad Sci U S A 2017;114:6346-6351.
40. Bevacqua M, Baldo F, Pastore S, Valencic E, Tommasini A, Maestro A,
Rabusin M, Arbo A, Barbi E. Off-Label Use of Sirolimus and Everolimus in
a Pediatric Center: A Case Series and Review of the Literature. Paediatr
Drugs 2019;21:185-193.